Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
11.36
-2.08 (-15.48%)
At close: Aug 1, 2025, 4:00 PM
11.45
+0.09 (0.79%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Laboratory Solutions
4.61B
Log In
Log In
Log In
Log In
Upgrade
Laboratory Solutions Growth
-3.72%
Log In
Log In
Log In
Log In
Upgrade
Bioscience Production
2.17B
Log In
Log In
Log In
Log In
Upgrade
Bioscience Production Growth
-0.33%
Log In
Log In
Log In
Log In
Upgrade
Proprietary Materials & Consumables
-
Log In
Log In
Log In
Log In
Upgrade
Proprietary Materials & Consumables Growth
-
Log In
Log In
Log In
Log In
Upgrade
Third Party Materials & Consumables
-
Log In
Log In
Log In
Log In
Upgrade
Third Party Materials & Consumables Growth
-
Log In
Log In
Log In
Log In
Upgrade
Services & Specialty Procurement
-
Log In
Log In
Log In
Log In
Upgrade
Services & Specialty Procurement Growth
-
Log In
Log In
Log In
Log In
Upgrade
Equipment & Instrumentation
-
Log In
Log In
Log In
Log In
Upgrade
Equipment & Instrumentation Growth
-
Log In
Log In
Log In
Log In
Upgrade

Capex by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Americas Capital Expenditures
-
Log In
Log In
Log In
Log In
Upgrade
Americas Capital Expenditures Growth
-
Log In
Log In
Log In
Log In
Upgrade
Europe Capital Expenditures
-
Log In
Log In
Log In
Log In
Upgrade
Europe Capital Expenditures Growth
-
Log In
Log In
Log In
Log In
Upgrade
AMEA Capital Expenditures
-
Log In
Log In
Log In
Log In
Upgrade
AMEA Capital Expenditures Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBITDA by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Americas Adjusted EBITDA
-
Log In
Log In
Log In
Log In
Upgrade
Americas Adjusted EBITDA Growth
-
Log In
Log In
Log In
Log In
Upgrade
Europe Adjusted EBITDA
-
Log In
Log In
Log In
Log In
Upgrade
Europe Adjusted EBITDA Growth
-
Log In
Log In
Log In
Log In
Upgrade
AMEA Adjusted EBITDA
-
Log In
Log In
Log In
Log In
Upgrade
AMEA Adjusted EBITDA Growth
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Adjusted EBITDA
-
Log In
Log In
Log In
Log In
Upgrade
Corporate Adjusted EBITDA Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Americas
-
Log In
Log In
Log In
Log In
Upgrade
Americas Growth
-
Log In
Log In
Log In
Log In
Upgrade
Europe
-
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade
AMEA
-
Log In
Log In
Log In
Log In
Upgrade
AMEA Growth
-
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Laboratory Solutions Adjusted Operating Income
598.00M
Log In
Log In
Log In
Log In
Upgrade
Laboratory Solutions Adjusted Operating Income Growth
-6.21%
Log In
Log In
Log In
Log In
Upgrade
Bioscience Production Adjusted Operating Income
558.20M
Log In
Log In
Log In
Log In
Upgrade
Bioscience Production Adjusted Operating Income Growth
-2.76%
Log In
Log In
Log In
Log In
Upgrade
Corporate Adjusted Operating Income
-66.40M
Log In
Log In
Log In
Log In
Upgrade
Corporate Adjusted Operating Income Growth
17.37%
Log In
Log In
Log In
Log In
Upgrade